European Union vs Madagascar: Prevalence of anemia among women of reproductive age
European Union
17.1%
in 2023
Madagascar
37.2%
in 2023
European Union rank
43rd
Madagascar rank
40th
Prevalence of anemia among women of reproductive age over time
- European Union
- Madagascar
How they compare
Madagascar currently reports 37.2% against 17.1% in European Union, a difference of 20.1%.
That makes Madagascar's figure about 2.2 times European Union's.
Across all 24 years both countries report, Madagascar has been ahead every year.
European Union ranks 43rd and Madagascar ranks 40th of 47 groups.
Madagascar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | European Union | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.7% | 34.5% | 21.8% | Madagascar |
| 2010s | 13.5% | 33.3% | 19.7% | Madagascar |
| 2020s | 16.1% | 36.1% | 20.0% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, European Union or Madagascar?
- Madagascar, at 37.2% against 17.1% in European Union as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between European Union and Madagascar?
- 20.1%, with Madagascar ahead.
- How many years of comparable data are there for European Union and Madagascar?
- 24 years are reported by both, from 2000 to 2023.
- How do European Union and Madagascar rank globally for prevalence of anemia among women of reproductive age?
- European Union ranks 43rd and Madagascar ranks 40th of 47 groups.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.